![](/img/cover-not-exists.png)
High-throughput matrix screening in ovarian cancer cells identifies synergistic drug combinations with the second mitochondrial-derived activator of caspases (SMAC) mimetic birinapant (TL32711)
Bunch, K.P., Goldlust, I.S., Thomas, C.J., Annunziata, C.M.Volume:
137
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.01.522
Date:
April, 2015
File:
PDF, 73 KB
english, 2015